NCT05110625

Brief Summary

The aim of this study is to develop and evaluate a low intensity, multifaceted, digital health intervention to prevent T2DM based on: i) the use of a system comprising mobile health (mHealth) technology integrated with electronic health records to send tailored text messages (SMSs) promoting lifestyle changes in people at risk of T2DM, and, ii) the provision of online education to primary healthcare workers about prediabetes management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
365

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 5, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 8, 2021

Completed
23 days until next milestone

Study Start

First participant enrolled

December 1, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
Last Updated

August 23, 2024

Status Verified

August 1, 2022

Enrollment Period

1.5 years

First QC Date

October 5, 2021

Last Update Submit

August 22, 2024

Conditions

Keywords

Prediabetic StateGlycemic ControlTelemedicine

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline Glycated Hemoglobin (HbA1C) at 6 months

    Baseline and Postintervention (6 months)

Secondary Outcomes (26)

  • Change from Baseline Fasting blood glucose at 6 months

    Baseline and Postintervention (6 months)

  • Change from Baseline Triglycerides at 6 months

    Baseline and Postintervention (6 months)

  • Change from Baseline Total Cholesterol at 6 months

    Baseline and Postintervention (6 months)

  • Change from Baseline low density cholesterol (LDL) at 6 months

    Baseline and Postintervention (6 months)

  • Change from Baseline high density cholesterol (HDL) at 6 months

    Baseline and Postintervention (6 months)

  • +21 more secondary outcomes

Other Outcomes (3)

  • Number of eligible patients

    Baseline

  • Recruitment rate

    Baseline

  • Follow-up rate

    Postintervention (6 months)

Study Arms (3)

Intervention A

EXPERIMENTAL

Participants will receive Messaging Intervention

Behavioral: preDIABE-TEXT

Intervention B

EXPERIMENTAL

Participants will receive messaging intervention plus online education to their primary healthcare workers

Behavioral: preDIABE-TEXTOther: Online Education

Control

NO INTERVENTION

Participants will receive usual care only, and their healthcare workers will not receive online education

Interventions

preDIABE-TEXTBEHAVIORAL

Participants will receive text messages (three per week) in their mobile phones during six months.

Intervention AIntervention B

Primary healthcare workers will receive an online educacion about prediabetes. This intervention will aim at: 1) raising awareness about the importance of T2DM prevention; 2) increasing knowledge about effective strategies for diabetes prevention; 3) improving knowledge about brief counselling techniques; and, 4) enhancing communication skills.

Intervention B

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Registered in the Public Health Service of the Balearic Islands
  • At risk of T2DM (HbA1c from 6% to 6.4% within the last 3 months or two consecutive values of fasting plasma glucose 110-125mg/dl within the last 12 months, or both)
  • With access to a mobile device able to receive text messages.

You may not qualify if:

  • People not able to read messages in Spanish
  • Patients with severe mental conditions.
  • Patients on an antidiabetic medication regime
  • Pregnancy: currently or during the previous 12 months
  • People planning to change healthcare centre during the intervention period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ignacio Ricci-Cabello

Palma de Mallorca, Balearic Islands, 07002, Spain

Location

Related Publications (3)

  • Soriguer F, Goday A, Bosch-Comas A, Bordiu E, Calle-Pascual A, Carmena R, Casamitjana R, Castano L, Castell C, Catala M, Delgado E, Franch J, Gaztambide S, Girbes J, Gomis R, Gutierrez G, Lopez-Alba A, Martinez-Larrad MT, Menendez E, Mora-Peces I, Ortega E, Pascual-Manich G, Rojo-Martinez G, Serrano-Rios M, Valdes S, Vazquez JA, Vendrell J. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 2012 Jan;55(1):88-93. doi: 10.1007/s00125-011-2336-9. Epub 2011 Oct 11.

    PMID: 21987347BACKGROUND
  • Chow CK, Redfern J, Hillis GS, Thakkar J, Santo K, Hackett ML, Jan S, Graves N, de Keizer L, Barry T, Bompoint S, Stepien S, Whittaker R, Rodgers A, Thiagalingam A. Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease: A Randomized Clinical Trial. JAMA. 2015 Sep 22-29;314(12):1255-63. doi: 10.1001/jama.2015.10945.

    PMID: 26393848BACKGROUND
  • Mira-Martinez S, Malih N, Angullo-Martinez E, Zamanillo-Campos R, Yanez AM, Bennasar-Veny M, Gomez-Juanes R, Konieczna J, Jimenez R, Serrano-Ripoll MJ, Fiol-deRoque MA, Leiva A, Galmes-Panades AM, Miralles-Xamena J, Vidal-Thomas MC, Gomez-Cobo C, Gervilla E, Ona-Gil JI, Ricci-Cabello I. A Multifaceted Digital Intervention for the Prevention of Type 2 Diabetes Mellitus in Primary Care (PREDIABETEXT): Cluster Randomized Trial. J Med Internet Res. 2025 Oct 9;27:e70981. doi: 10.2196/70981.

MeSH Terms

Conditions

Prediabetic State

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 5, 2021

First Posted

November 8, 2021

Study Start

December 1, 2021

Primary Completion

May 31, 2023

Study Completion

May 31, 2023

Last Updated

August 23, 2024

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will share

We will share all collected IPD after anonymization

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Data will be available from January 2023 onwards
Access Criteria
Upon a reasonable request, we will grant access to public organizations. The PI of the project will review the requests.

Locations